APTINYX INC (APTX)

US03836N1037 - Common Stock

0.061  -0.04 (-39%)

After market: 0.074 +0.01 (+21.31%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

APTINYX INC

NASDAQ:APTX (5/18/2023, 7:22:26 PM)

After market: 0.074 +0.01 (+21.31%)

0.061

-0.04 (-39%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap4.13M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

APTX Daily chart

Company Profile

Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. The company is headquartered in Evanston, Illinois and currently employs 12 full-time employees. The company went IPO on 2018-06-21. The firm is focused on the discovery, development, and commercialization of proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. The firm focuses on targeting and modulating N-methyl-D-aspartate receptors, (NMDArs), which are vital to the normal and effective function of the brain and nervous system. The firm's NYX-783 is in Phase 1 clinical development for the treatment of opioid use disorder (OUD), and in preclinical development for the treatment of alcohol use disorder. NYX-783 modulates NMDA receptors to increase glutamatergic activity in key regions and may act to enhance extinction learning and alleviate the emotional symptoms of opioid withdrawal. The firm's NMDAr modulator discovery platform builds on NMDAr biology. The platform has the potential to develop into a broad pipeline and product portfolio across an array of disorders of the brain and nervous system.

Company Info

APTINYX INC

1801 Maple Ave Ste 4300

Evanston ILLINOIS 60201

P: 18478710377.0

CEO: Norbert G. Riedel

Employees: 12

Website: https://www.aptinyx.com/

APTX News

News Imagea year ago - Aptinyx Inc.Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives
News Imagea year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!

News Imagea year ago - InvestorPlaceAMC Stock Alert: AMC Entertainment Launches Popcorn Line at Walmart

AMC Entertainment (AMC) stock is in the news after the movie theater company announced it will launch its own line of popcorn at Walmart.

News Imagea year ago - InvestorPlaceWhy Is AdaptHealth (AHCO) Stock Down 22% Today?

AdaptHealth (AHCO) stock is falling on Tuesday following the release of the company's earnings report for the fourth quarter of 2022.

News Imagea year ago - InvestorPlaceWhy Is Aptinyx (APTX) Stock Down 64% Today?

Aptinyx (APTX) stock is taking a beating on Tuesday after the company revealed poor results from a Phase 2 clinical trial.

News Imagea year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

APTX Twits

Here you can normally see the latest stock twits on APTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example